Azurvig 12,5 mg po potisku, oralna suspenzija
| Name | Azurvig 12,5 mg po potisku, oralna suspenzija |
|---|---|
| Marketing Authorisation Number | HR-H-180491620 |
| Active Substance | sildenafilcitrat |
| Composition | 1 ml suspenzije sadrži 35,1 mg sildenafilcitrata, što odgovara 25 mg sildenafila. Svaki potisak oslobađa 0,5 ml suspenzije koja sadrži 12,5 mg sildenafila (u obliku sildenafilcitrata). |
| Pharmaceutical Form | Oralna suspenzija |
| Manufacturer | Edefarm S.L., Villamarchante, Valencia, Španjolska Farmalider S.A., Alcobendas - Madrid, Španjolska Zinereo Pharma S.L.U., O Porrino, Pontevedra, Španjolska |
| Marketing Authorisation Holder | Alpen Pharma GmbH, Steinenfeld 3, Zell am Harmersbach, Njemačka |
| Marketing Authorisation Date | 28.03.2024 |
| MA Period of Validity | 28.03.2029 |
| Classification Number | UP/I-530-09/22-01/198 |
| Registration Number | 381-12-01/171-24-10 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | G04BE03 |
| Marketing status | nije stavljeno u promet |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
